J. Keith Joung

J. Keith Joung is an American pathologist and molecular biologist who holds the Robert B. Colvin Endowed Chair in Pathology at Massachusetts General Hospital and is Professor of Pathology at Harvard Medical School. He is a leading figure in the field of genome editing and has pioneered the development of designer nucleases and sensitive off-target detection methods. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Joung, J. Keith', query time: 0.03s Refine Results
  1. 1
    Chromatin regulation at the frontier of synthetic biology

    Chromatin regulation at the frontier of synthetic biology by Joung, J. Keith, Khalil, Ahmad S., Keung, Albert Jun Qi, Collins, James J.

    Published 2017
    Get full text
    Get full text
    Get full text
    Article
  2. 2
    A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions

    A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions by Khalil, Ahmad S., Lu, Timothy K., Bashor, Caleb, Ramirez, Cherie L., Pyenson, Nora C., Joung, J. Keith, Collins, James J.

    Published 2014
    Get full text
    Get full text
    Article
  3. 3
    Context influences on TALE–DNA binding revealed by quantitative profiling

    Context influences on TALE–DNA binding revealed by quantitative profiling by Rogers, Julia M., Reyon, Deepak, Sander, Jeffry D., Kellis, Manolis, Joung, J. Keith, Bulyk, Martha L., Barrera, Luis Alberto

    Published 2015
    Get full text
    Get full text
    Article
  4. 4
    ZFNGenome: A comprehensive resource for locating zinc finger nuclease target sites in model organisms

    ZFNGenome: A comprehensive resource for locating zinc finger nuclease target sites in model organisms by Voytas Daniel F, Zhang Feng, Sander Jeffry D, Kirkpatrick Jessica R, Reyon Deepak, Joung J Keith, Dobbs Drena, Coffman Clark R

    Published 2011-01-01
    Get full text
    Article
  5. 5
    Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway

    Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway by Ando, Koji, Shah, Ankur K., Sachdev, Vibhu, Kleinstiver, Benjamin P., Taylor-Parker, Julian, Welch, Moira M., Hu, Yiheng, Salgia, Ravi, Parvin, Jeffrey D., Ozonoff, Al, Rameh, Lucia E., Joung, J. Keith, Bharti, Ajit K., White, Forest M.

    Published 2017
    Get full text
    Get full text
    Article
  6. 6
    Genome Editing Technologies: Defining a Path to Clinic

    Genome Editing Technologies: Defining a Path to Clinic by Corrigan-Curay, Jacqueline, O'Reilly, Marina, Kohn, Donald B, Cannon, Paula M, Bao, Gang, Bushman, Frederic D, Carroll, Dana, Cathomen, Toni, Joung, J Keith, Roth, David, Sadelain, Michel, Scharenberg, Andrew M, von Kalle, Christof, Zhang, Feng, Jambou, Robert, Rosenthal, Eugene, Hassani, Morad, Singh, Aparna, Porteus, Matthew H

    Published 2017
    Get full text
    Get full text
    Article
  7. 7
    Computational and experimental methods for CRISPR-based saturation mutagenesis screens

    Computational and experimental methods for CRISPR-based saturation mutagenesis screens by Hsu, Jonathan Yee-Ting

    Published 2023
    Other Authors: “…Joung, J. Keith…”
    Get full text
    Thesis

Search Tools: